Your browser doesn't support javascript.
loading
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.
Cancer Discov ; 2(11): 1048-63, 2012 Nov.
Article in En | MEDLINE | ID: mdl-22915751

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Genes, BRCA1 / Poly(ADP-ribose) Polymerase Inhibitors / Phosphoinositide-3 Kinase Inhibitors Limits: Animals / Female / Humans Language: En Journal: Cancer Discov Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Genes, BRCA1 / Poly(ADP-ribose) Polymerase Inhibitors / Phosphoinositide-3 Kinase Inhibitors Limits: Animals / Female / Humans Language: En Journal: Cancer Discov Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States